Healthcare Sales & Marketing Network News: Tyvaso

Searching News Database: Tyvaso

HSMN NewsFeed - 1 Apr 2021
United Therapeutics Announces FDA Approval and Launch of Tyvaso(R) for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
Biopharmaceuticals FDA Product Launch

HSMN NewsFeed - 4 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
Biopharmaceuticals Licensing

HSMN NewsFeed - 23 Oct 2017
United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso(R) Inhalation System
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 9 Dec 2013
United Therapeutics Receives Subpoena From Office of Inspector General
Biopharmaceuticals

HSMN NewsFeed - 19 Feb 2010
United Therapeutics Corporation Withdraws European Marketing Authorization Application for Tyvaso for the Treatment of Pulmonary Arterial Hypertension
Biopharmaceuticals Regulatory

HSMN NewsFeed - 16 Mar 2009
United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso)
Biopharmaceuticals Drug Delivery FDA

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.